TTY Biopharma

TTY Biopharma is a leading Taiwanese pharmaceutical company specializing in the development and manufacturing of high-barrier drug delivery systems, particularly liposomal and microsphere technologies. The company focuses on four primary therapeutic areas: oncology, anti-infectives, healthcare (chronic diseases), and immunology. TTY Biopharma operates as a vertically integrated entity, encompassing research and development, clinical trials, and international-standard manufacturing facilities. They are well-known for their specialty generic drugs and have established a significant presence in the global market through strategic partnerships and licensing. The company is one of the few globally capable of producing complex liposomal formulations at a commercial scale.